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Cholinergic systems were linked to cognitive processes like attention and memory. Other neurotrans-
mitter systems having minor inﬂuence on cognitive functions – as shown by the weakness of the
effects of their selective lesions – modulate cholinergic functions. The serotonergic system is such a
system. Conjoined functional changes in cholinergic and serotonergic systems may have marked cog-
nitive consequences [Cassel JC, Jeltsch H. Serotoninergic modulation of cholinergic function in the central
nervous system: cognitive implications. Neuroscience 1995;69(1):1–41; Steckler T, Sahgal A. The role
of serotoninergic–cholinergic interactions in the mediation of cognitive behaviour. Behav Brain Res
1995;67:165–99].
A crucial issue in that concern is the identiﬁcation of the neuroanatomical and neuropharmacolog-
ical substrates where functional effects of serotonergic/cholinergic interactions originate. Approaches
relying on lesions and intracerebral cell grafting, on systemic drug-cocktail injections, or even on
intracerebral drug infusions represent the main avenues on which our knowledge about the role of
serotonergic/cholinergic interactions has progressed.
The present review will visit some of these avenues and discuss their contribution to what is currently
known on the potential or established implication(s) into memory functions of serotonergic/cholinergic
interactions. It will then focus on a brain region and a neuropharmacological substrate that have been
poorly studied as regards serotonergic modulation of memory functions, namely the medial septum and
its 5-HT1A receptors. Based on recent ﬁndings of our laboratory, we suggest that these receptors, located
on both cholinergic and GABAergic septal neurons, take part in a mechanism that controls encoding, to
C
0
dsome extent consolidation, but not retrieval, of hippocampal-dependentmemories. This control, however,
does not occur by the way of an exclusive action of serotonin on cholinergic neurons.
© 2008 Elsevier B.V. All rights reserved.
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. Introduction
At a very general level, cognitive functions can be deﬁned as
n animal’s capability to collect, encode, treat, store and use any
ind of knowledge about its environment. Such functions are orga-
ized into a series of distributed, structurally and functionally
nterconnected anatomically deﬁned modules. Schematically, one
uch module can be deﬁned according to both its general structure
i.e., the different constitutive brain regions and the connectivity
etwork enabling intra- and inter-regional information exchange)
nd its functional implications (i.e., the “mental” and behavioural
utputs it contributes to generate). Thus, each component of this
odule (for instance, a particular nucleus) comprises its own neu-
onsand its intrinsicneuronalnetwork, butalso isboth thesourceof
rojection ﬁbres sent to other components and the target of neuro-
hemically deﬁned afferent ﬁbres originating in other structures of
he brain. These ﬁbres, whether efferent or afferent, can be deﬁned
t different levels of analysis, e.g., according to the type of path-
ay(s) towhich theybelongor to their neurochemical identity (e.g.,
holinergic, noradrenergic, serotonergic, etc.).
Some regions of the mammalian brain receive both a seroton-
rgic and a cholinergic innervation (e.g., the hippocampus, the
ortical mantle), or comprise cholinergic nuclei that receive an
xtrinsic serotonergic innervation (e.g., basal forebrain nuclei, such
s the septum). Providing an exhaustive neuroanatomical survey
f the various serotonergic and cholinergic nuclei or targets, of
he distribution of their interconnections or terminal ﬁelds, and
f the various receptor sites found therein lies beyond the scope
f the present review. On these matters, the reader is referred
o previous publications dealing with serotonergic and choliner-
ic neuroanatomy, neuropharmacology andneurophysiology in the
rain [3,24,27,74,111,132,142].
It can be brieﬂy reminded, however, that the brain regions
eceiving both a serotonergic and a cholinergic innervation,
hether extrinsic and/or intrinsic, encompass, among other struc-
ures, the striatum, the cortex and the hippocampus. These three
egions are recognized to play a crucial role in various forms of cog-
itive processes, perhaps more particularly in memory functions,
e it in terms of declarative-like or non-declarative-like ones.
Several studieshaveshownthatan interactionbetweenseroton-
rgic and cholinergic processes in one or the other of these regions
ay result in physiological modiﬁcations that the manipulation of
nly one of these systems is unable to mimick, either qualitatively
r quantitatively. The majority of the arguments demonstrating
hat an interaction between cholinergic and serotonergic processes
ave a functional relevance were obtained with neuro- and psy-
hopharmacological approaches. For example, itwas shown that, in
he rat hippocampus, the release of acetylcholine by terminals orig-
nating in themedial septumand thediagonal bandof Brocamaybe
nhibited by a local activation of 5-HT1B [20,21,37,96,118,123] and
robably also 5-HT3 receptors [60]. Under the condition of a sys-
emic activation, this release can be facilitated via the activation
f 5-HT1A as well as 5-HT3 receptors, or inhibited via the acti-
ation of 5-HT1B (5-HT1D in the guinea-pig) and 5-HT4 receptors
19,43,73,104]. There is also evidence that a serotonergic denerva-
ion of the hippocampus is able to facilitate the evoked release of
cetylcholine in hippocampal slices [18]. In the cortex, the release
2
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f acetylcholine may be locally controlled by 5-HT1B and 5-HT3
nhibitory receptors [42,123], whereas systemic activation of 5-
T1A and 5-HT4 receptors induces facilitatory effects [5]. Finally, in
he striatum, local inhibition of the cholinergic tonusmay bemedi-
ted by 5-HT1 and/or 5-HT2 receptors [61] and, under the condition
f systemic activation, by 5-HT1A receptors [6].
All these receptor sites are potential neuropharmacological
argets by which serotonin (5-hydroxytryptamine or 5-HT) may
nﬂuence cholinergic processes and affect cognitive function,
ncluding learning and memory [for the detail, see 36 or 131].
In the present review,wewill consider serotonergic–cholinergic
nteractions and their relevance to memory functions. In a ﬁrst
art, we will glance at very general approaches relying upon
ore or less selective lesion techniques, combined or not to
ntracerebral transplantations of neurochemically deﬁned popula-
ions of fetal neurons (i.e., cholinergic and/or serotonergic). These
pproaches have contributed to stimulate the interest in a possible
ole for cholinergic–serotonergic interactions inmemory functions.
n a second part, we will focus on systemic drug administration
pproaches by presenting data showing the effects induced by
ystemic treatment with serotonergic compounds on cholinergic
rafts, as well as after cholinergic lesions or receptor blockade.
hese pharmacological approaches have the advantage, among
ome others, of enabling an investigation of the contribution of
ifferent subtypes of receptors. Our main focus, there, will be the
-HT1A receptor. This receptor is negatively coupled to adenylyl
yclase and to a direct activation of inwardly rectifying potassium
onductance, thus contributing to membrane hyperpolarization
nd reducing the probability of cell ﬁring when activated [70,71].
inally, based on ﬁndings of our and other laboratories, of which
ome are very recent [84], others yet unpublished, the last part of
his reviewwill concentrate on the possible contribution of 5-HT1A
eceptors of the medial septum to spatial memory encoding and
onsolidation.Wewill then discuss the extent to which this contri-
ution may operate via an action mediated by septohippocampal
holinergic neurons.
. Lesion and cell grafting approaches
For many years, experiments in behavioural neurobiology have
sed lesion techniques that selectively damaged well delineated
egions of the brain (nuclei and/or pathways) in order to assess the
ehavioural correlates of such damage. While very useful in study-
ng and establishing possible structure–function relationships,
uch approaches were of limited utility as to the understanding of
he neuropharmacological regulations involved in the modulation
f region- or system-speciﬁc functions. The investigation of such
odulation(s) required pharmacological approaches and/or lesion
echniques that were selective, before anything else for particu-
ar neurotransmitter systems. Approaches based on neurochemical
electivity of lesions have become possible only with the emer-
ence of a series of compoundswith neurotoxic properties oriented
owards neurochemically deﬁned populations of neurons..1. Serotonergic and cholinergic neurotoxins
For example, 5,6-dihydroxytryptamine (5,6-DHT) and 5,7-
ihydroxytryptamine (5,7-DHT), two substances that were able to
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electively damage the serotonergic neurons (under the condition
f a protection of noradrenergic neurons by pre-treatment with
norepinephrine reuptake blocker such as desipramine) were
ntroduced in the early seventies [7–9]. Subsequently, 5,7-DHT,
hich proved to be more useful than 5,6-DHT, has been used to
amage serotonergic neurons in the rodent brain and to investigate
he functional correlates of the lesion at various levels of analysis,
ncluding memory [79,91]. Brieﬂy, the mechanism by which
his neurotoxin produces selective serotonergic damage relies
pon auto-oxidation and other enzymatic-mediated oxidation
eactions of 5,7-DHT, after its rapid uptake into serotonergic
eurons. The reaction products of these oxidations, and especially
-hydroxytryptamine-4,7-dione, are toxic for the neurons inwhich
hey occur [133,145].
Concerning the cholinergic selectivity of neuronal lesions,
F64A (ethylcholine aziridinium) was probably one of the ﬁrst
ompounds to open some promising perspectives. This aziri-
inium moiety-containing molecule (aziridinium is cytotoxic) is
n analog of choline and has a strong afﬁnity for the high afﬁn-
ty choline transporter, which it may inhibit reversibly or not,
epending on its concentration [64]. It is noteworthy that the
peciﬁcity of AF64A has been questioned [55,65,66,93]. Neverthe-
ess, it seems that under conditions of appropriate dosage and
reparation methods, the toxic effects of AF64A might reach a sat-
sfactory degree of cholinergic speciﬁcity and can be the cause of
emory dysfunctions [55]. Another compound, named 192 IgG-
aporin, has become available in the early nineties [143]. It is
n immunotoxin that appears to be more speciﬁc for cholinergic
eurons, at least in the basal forebrain of the rat. This toxin is
onstituted by a monoclonal antibody that recognizes the p75NGF
eceptor, and which is coupled to the ribosomal toxin saporin
15,23,68,98,108,143]. Saporin is extracted from the plant Saponaria
fﬁcinalis. There exists a recent murine equivalent of it [16], which
ermits to induce lesions that are quite comparable in extent
nd selectivity to those obtained in rats with 192 IgG-saporin
106].
The behavioural effects of this immunotoxin seem, however, to
epend on its way of administration. When infused into the cere-
ral ventricles, it reaches virtually all basal forebrain cholinergic
argets bearing p75NGF receptor and also other p75NGF receptor-
earing neurons such as motoneurons [12] as well as Purkinje
ells in the cerebellum [140]. Under such conditions, deﬁcits have
een observed in several tasks taxing working or reference mem-
ry (Morris water-maze, radial maze, passive avoidance, operant
elayed matching-to-position task) and in a relatively replicable
ay [e.g., 85,86,90]. Conversely,when injected intraparenchymally,
ither into the septal region or the nucleus basalis magnocellularis,
he cholinergic damage observed was conﬁned to the structure in
hich 192 IgG-saporin had eventually been injected, and mem-
ry deﬁcits were generally weak or inexistent, unless the doses
f 192 IgG-saporin were large and could have induced addi-
ional non-cholinergic damage (e.g., to septal GABAergic neurons,
robably as a consequence of toxins resulting from the degen-
ration of cholinergic neurons [77]). It is noteworthy, however,
hat intrabasalis injections of the immunotoxin produced weak
o severe deﬁcits of attentional functions, for example in the
ve-choice serial reaction time task, although having no effect
n memory functions, as found in the radial and the Morris
ater mazes [58,67,89,97,122]. This clear-cut shift between the
emory effects that were expectable from the so-called cholin-
rgic hypothesis of geriatric memory dysfunctions and those that
ere actually observed has contributed to challenge the cholin-
rgic hypothesis of memory functions [e.g., 6]. This issue has
een commented and discussed in various recent reviews [e.g.,
02,114].
t
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.2. Combined cholinergic and serotonergic lesions
To the best of our knowledge, we have been the ﬁrst ones
o use 192 IgG-saporin lesions in combination with another type
f neurochemically selective damage, namely 5,7-DHT-induced
erotonindepletion. In general, lesion experiments basedon intrac-
rebroventricular injections of 192 IgG-saporin and5,7-DHT clearly
uggest that the cognitive effects of a cholinergic denervation of
oth the hippocampus (septal lesions) and the neocortex (nucleus
asalis lesions) canbe exacerbatedby concomitant andwidespread
erotonin depletion. Indeed, we found that 5,7-DHT, used in com-
ination with 192 IgG-saporin, induced working-memory deﬁcits
n the water-maze and in the radial maze, which neither toxin pro-
uced when it was injected alone. In that way, a study assessing
ehavioural (locomotor activity, forced T-maze alternation, beam
alking, Morris water-maze and radial-maze) and neurochemical
ffects of intracerebroventricular injections of both the choliner-
ic toxin 192 IgG-saporin and the serotonergic toxin 5,7-DHT in
ong-Evans rats, showed that cholinergic lesions, which reduced
he concentration of acetylcholine by about 40% in the hippocam-
us but had no effect in the striatum, induced only severe motor
eﬁcits. Serotonergic lesions, which reduced the concentration of
erotonin by 80% in the hippocampus and the striatum, produced
iurnal andnocturnal hyperactivity but noother behavioural effect.
inally, rats with combined lesions were more active than those
ith only serotonergic lesions, showed motor dysfunctions similar
o those found in rats with cholinergic lesions alone, and exhibited
mpaired performance in the T-maze alternation test, the water-
aze working memory test and the radial-maze [90]. A consistent
nding in these series of lesion experiments was that serotonin
epletion alone did not produce detrimental effects in these tasks,
hether assessing spatial or non-spatial working memory, or even
eference-memory [e.g., 57,88,90; but see 146]. However, another
tudy conducted in our group showed that serotonin depletion
onﬁned to the hippocampus – by injections of 5,7-DHT directly
nto the cingular bundle and the ﬁmbria–fornix – could atten-
ate some of the behavioural deﬁcits produced by a large dose
f 192 IgG-saporin, which, this time, was injected directly into
he medial septum and the diagonal band of Broca [88]. In this
xperiment, rats with single or combined damage were tested for
ocomotor activity, spontaneous T-maze alternation, sensorimotor,
ater maze and radial maze performance. The data showed that
he cholinergic lesions, which decreased the hippocampal con-
entration of acetylcholine by about 65% [see also 39], induced
octurnal hyperlocomotion, reduced T-maze alternation, impaired
oth reference-memory in the water maze and working-memory
n the radial maze, but had no effect on sensorimotor performance
nd working-memory in the water maze. Again, 5,7-DHT lesions,
hich decreased the concentration of hippocampal serotonin by
bout 55%, failed to induce any behavioural deﬁcit. Nevertheless,
n the group of rats given combined lesions, all deﬁcits produced
y the cholinergic lesions were observed; surprisingly, however,
he nocturnal hyperactivity and the working-memory deﬁcits in
he radial maze were signiﬁcantly attenuated. Interestingly, we
ould also establish that following serotonergic denervation of the
ippocampus (by 5,7-DHT lesions), the electrically evoked release
f acetylcholine was facilitated in hippocampal slices. Even more
nteresting was the observation that this facilitation was counter-
alanced by intrahippocampal grafts rich in serotonergic neurons
18]. These results suggest that the reduction of the serotonergic
one in the hippocampus may compensate for some dysfunctions
ubsequent to a loss of cholinergic hippocampal inputs.
This observation is in close concordance with psychophar-
acological data showing that spatial memory deﬁcits observed
n a two-platform spatial discrimination task, and which was
ral Br
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nduced by intrahippocampal infusions of scopolamine, an
ntimuscarinic drug, could be reversed or attenuated by the
ctivation of somato-dendritic 5-HT1A receptors in the raphe;
he activation was achieved by microinfusions of 8-OH-DPAT (8-
ydroxy-2-(di-n-propyl-amino)-tetralin), a mixed 5-HT1A/5-HT7
gonist. Such microinfusions reduce the serotonergic tonus in
he target areas of the ascending serotonergic pathways [28,30;
ee also below]. Similar observations were made when hip-
ocampal 5-HT1A receptors were blocked by intrahippocampal
njections of WAY 100635, a selective 5-HT1A antagonist in
copolamine-treated rats, as was also the case after systemic
njections of this 5-HT1A receptor antagonist [29,33; in these
tudies, scopolamine was infused bilaterally into the CA1 region
f the dorsal hippocampus, 10min before each training session].
hus, it seems that the negative effects on cognitive functions
f muscarinic blockade can be counterbalanced by a systemic
lockade of post-synaptic 5-HT1A receptors or by an activa-
ion of the somato-dendritic 5-HT1A receptors in the raphe
uclei.
Serotonin could either inhibit (via presynaptic mechanisms
nvolving heteroreceptors) or facilitate (via polysynaptic loops
tarting postsynaptically) the release of acetylcholine. Suchmecha-
ismsarepresent inboth thehippocampusand thecortex, although
hey donot necessarily involve the same subtypes of pre- or postsy-
aptic receptors. Whatever be these mechanisms, almost all lesion
xperiments involving cholinergic and serotonergic damage in the
imbic system converge towards the conclusion that theremay be a
erotonergicmodulationof cholinergic function, and that thismod-
lation could take part in spatial reference and working memory,
s well as in non-spatial memory. Whether serotonin depletion
ttenuates or exacerbates memory deﬁcits associated with 192
gG-saporin lesions seems, however, to depend on which brain
tructures are affected and how the toxins have been delivered to
arget nuclei (intracerebroventricularly vs. intraparenchymally).
.3. Co-grafting fetal cell suspensions rich in cholinergic and
erotonergic neurons
As regards the septohippocampal system, the implication of
holinergic–serotonergic interactions in cognitive functions is
urther supported by studies using techniques that consisted in
o-grafting neuroanatomically and/or neurochemically deﬁned
opulations of neurons into denervated structures of the brain,
n general without any particular neurochemical selectivity.
ctually, following massive hippocampal denervation (by e.g.,
ransection or aspiration of the ﬁmbria–fornix and cingular bundle
athways), fetal cell suspension grafts providing new cholinergic
grafts prepared from the region of the fetal brain including the
edial septum and the diagonal band of Broca) and serotonergic
grafts prepared from the mesencephalic raphe) innervations to
he hippocampus induced some cognitive recovery that none of
he single graft providing the hippocampus with only one or the
ther of these innervations was able to foster. There are several
rticles based on such a grafting approach [4,76,107], which clearly
uggest that a serotonergic/cholinergic interaction may have cog-
itive relevance, as was already the case for the aforementioned
ombinations of selective lesion approaches. For instance, in rats
iven radiofrequency (and thus unselective) lesions of the medial
eptum combined with intracerebroventricular injections of
,7-DHT, Nilsson and his collaborators were the ﬁrst ones to study
he behavioural effects of septal grafts alone (rich in cholinergic
eurons), raphe grafts alone (rich in serotonergic neurons), or a
ombination of both types of grafts, which they termed “co-grafts”
107]. Single and co-grafts were placed into the hippocampus and
eference memory was assessed in a Morris water maze. Whereas
r
t
p
t
tain Research 195 (2008) 86–97 89
either type of single graft produced beneﬁcial effects on water-
aze performance,whether assessed 2 or 10months after grafting,
he combined grafts, which also failed to produce effects at the
arly delay, had improvedmemory performance at the longest one.
Similar observations were made following electrolytic [76] or
spiration – and thus largely unselective – lesions of the ﬁmbria,
he dorsal fornix and the overlying cingular bundle [4]. Under
ther experimental conditions (i.e., serotonergic lesions combined
o partial cholinergic lesions in the septal region), it appeared
hat even the sole serotonergic reinnervation of the hippocampus
as sufﬁcient to promote signiﬁcant recovery of spatial reference
s well as working memory performance in a water-maze task
119]. However, while all these data support an implication of both
erotonergic and cholinergic processes in cognitive function, and
erhaps may ﬁt with the idea of a serotonergic modulation of
ome cognitive abilities in which cholinergic mechanisms were
roposed to have a signiﬁcant role, they have little or limited value
s for theunderstandingof thepharmacological substrates involved
n these modulatory interactions (where in the brain, which sys-
ems, onwhich receptors?). Furthermore, they could be considered
ontradictory to the aforementioned data showing that a reduced
erotonergic tonusmayhavebeneﬁcial effectsonmemory. It should
e kept in mind, however, that the co-grafting approach has been
arried out in rats subjected to massive hippocampal denervations
nd that the determinant factor of behavioural recovery in such
ase might have been the restoration of serotonergic–cholinergic
nteractions, and perhaps even more that of a certain balance in
he cooperation between both transmitter systems.
. Systemic drug administration combined to other
pproaches
Approaches that have much better contributed and still
ontribute to the understanding of the neuropharmacologi-
al substrates of cognitively relevant cholinergic–serotonergic
nteractions are of the pharmacological type and rely upon
eceptor-targeted drug administrations. If they lack neuroanatom-
cal selectivity when the drugs are given systemically, they have
he advantage of both enabling an investigation of the contribution
f various receptor subtypes and being easily combinable to other
echnical approaches.Although therehavebeenseveral studies that
nvestigated theeffects on learningandmemoryof avarietyof com-
ounds acting on 5-HT receptors in intact rodents [e.g., 94,104],
his third section will only focus on two of such combinations:
hat of serotonergic ligand administrations with grafts of cholin-
rgic neurons, and that of serotonergic ligand administrationswith
holinergic lesions or drugs blocking cholinergic receptors.
.1. Modulation of cholinergic graft-induced effects by systemic
reatment with serotonergic drugs
Concerning this point, we can start by mentioning one study
ssessing the effects of septal grafts on acetylcholine release from
at hippocampus following selective 192 IgG-saporin lesion [69].
n this study, the cholinergic inputs to the rat hippocampus were
esioned by intraseptal injections of 192 IgG-saporin. After 15 days
ost-surgical rest, fetal septal cells were grafted into the hip-
ocampus and, 13months later, hippocampal acetylcholine release
as studied using an in vivo microdialysis technique. The lesions
educed basal acetylcholine release to 20% of normal, but this
elease was enhanced, although not totally compensated for by
he graft (71%). As it is well known that serotonergic pathways
roject from raphe nuclei to cortical and limbic regions, and that
he hippocampal cholinergic functions are modulated by sero-
onergic afferents [43], we investigated whether evidence could
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e brought to light showing that the graft-derived acetylcholine
elease underwent a serotonergicmodulation. To this end,we stud-
ed the effects of citalopram (100M), a speciﬁc serotonin uptake
nhibitor, and of the mixed 5-HT1A/5-HT7 receptor agonist 8-OH-
PAT (0.5mg/kg; s.c.) on the hippocampal acetylcholine release
n sham-operated, lesion-only, and grafted rats. The retrodialy-
is of citalopram enhanced the hippocampal acetylcholine release
n the grafted hippocampus to the same extent as it did in the
ham-operated controls. These observations showed that when
ippocampal serotonergic nerve terminals released more sero-
onin, there was an enhanced release of acetylcholine from the
rafted tissue [56]. Most probably this effect was indirect and may
ave implicated extrahippocampal serotonin-dependent regula-
ions (see below). The systemic administration of 8-OH-DPAT also
nhanced acetylcholine release from the grafted tissue, showing
hat the implantation of septal grafts rich in cholinergic neu-
ons into themassively denervated hippocampus normalized some
europharmacological aspects of cholinergic–serotonergic interac-
ions. It is improbable, however, that 8-OH-DPAT acted directly
n 5-HT1A receptors located on cholinergic neurons, since these
eceptors, when activated, should theoretically have an inhibitory
nﬂuence on neuronal excitability. In addition, in rats subjected to
ntrahippocampal grafts rich in cholinergic neurons after exten-
ive ﬁmbria–fornix lesions, using a slice superfusion approach, we
ould not demonstrate that the application of 8-OH-DPAT to graft-
earing slices actually inﬂuenced the electrically evoked release of
cetylcholine [37].
.2. Effects of serotonergic drugs after cholinergic lesions or
eceptor blockade
The concurrent manipulations of both systems with drugs
elective for given receptor subtypes allows to setup a better
haracterization of the pharmacological substrates underlying the
holinergic/serotonergic interactions. Brieﬂy, and just to illustrate
his issue, the activation of 5-HT1A or 5-HT1B receptors, as well
s the inhibition of 5-HT2 receptors (the administration route of
he ligands being intraperitoneal or directly intraseptal) exacer-
ated a memory deﬁcit (e.g., assessed in spontaneous alternation,
assive avoidance andwatermaze tasks) produced by centralmus-
arinic blockade or by cholinergic lesions in rats [87,109,120,121].
onversely, a systemic blockade of 5-HT3 receptors was found
o attenuate the cognitive deﬁcits induced by central cholinergic
isruption in a passive-avoidance or a Morris water-maze task
25,41,44,116,117]. In vitro ﬁndings showed that an application of
erotonin or of serotonergic agonists or antagonists to stimulated
lices from given brain regions may alter the evoked release of
cetylcholine. However, if one excepts the case of superfusion
xperiments or experiments carried out on synaptosomes, these
ndings donot necessarily demonstrate that the serotonergicmod-
lation is directly occurring on the cholinergic terminals by means
f an action on serotonergic heteroreceptors. In vivo, the prob-
em gets even more complicated as the serotonergic inﬂuence on
holinergic function, especiallywhendrug treatments are adminis-
eredsystemically,may involvecomplexpolysynaptic loops, several
rain regions at once and various neurotransmitter systems. Thus,
lthough a change in the serotonergic input may result in a modiﬁ-
ation of the cholinergic output, the number of intermediate events
nd their neurochemical identity remain largely unknown. Here,
elective lesion techniquesmay bemore useful tools to explore the
tructural organization and the functional substrates of such loops.
inally, at the most integrated level of organization, namely that of
he organism, the degree of complexity in regulation mechanisms
eaches its maximum. At this level, the functional consequences
f an interaction do not necessarily suppose two neurotransmitter
w
r
l
s
Uain Research 195 (2008) 86–97
ystems to cooperate or to interact directly (for example, serotonin
eing necessarily activating heteroreceptors located on the cholin-
rgic terminal or elsewhere on the neuron). The consequences of
uch an interaction may also be determined by the cooperation
etween various functions that work in parallel, and which can
e themselves analyzed as resulting from interactions involving
variety of transmitter systems in the brain. Actually, that sero-
onin may modulate cognitive functions by a more or less direct
nﬂuence on cholinergic mechanisms is a concept that has a proper
euristic value. This value, however, is equivalent to that of con-
idering that serotonin produces a functional change at the level
f the organism (for example, on attentional processes or arousal),
hich would allow enhanced efﬁciency of the cholinergic contri-
ution to another kind of function in the organism (for example,
earning).
Whatever may be, all aforementioned studies, which in no case
hould be considered as being listed in an exhaustive way herein,
oint towards an important role for cholinergic–serotonergic inter-
ctions in cognitive functions. Among the serotonergic receptors
nvolved in the regulation of such interactions, the 5-HT1A ones
re far from being those having the weakest interest. For instance,
heir blockade was shown to exert very strong beneﬁcial effects in
ariousmodels ofmemory impairments, including cholinergic dys-
unctions [125] and, as such, appear as one of the interesting targets
o tackle the cognitive symptomatology accompanying a neurode-
enerative disease such as Alzheimer’s disease [26,100,124]. As said
n Section 1, these receptors arewidely distributed in the brain, and
he question of their role has been addressed in structures such as
he hippocampus, cortex or striatum, whether from a neurophar-
acological or behavioural perspective [34,54,100]. The septum is
ne of the brain structures in which a relatively large number of
-HT1A receptors are also found. Surprisingly, it has received little
ttention as regards the implication of this subtype of serotonergic
eceptors in memory functions.
. Intracerebral drug infusion approaches: focus on 5-HT1A
eceptors of the medial septum
Considering the limits of lesion and psychopharmacological
pproaches relying upon systemic administrations of drugs or drug
ocktails, and even of the combination of both, more powerful
pproaches,whichuse intraparenchymal and thus target-restricted
rug administration techniques, have been developed. In experi-
ental animals, suchapproaches canbe carriedout relatively easily
n order to characterize the functional consequences of local drug
nfusions. It is noteworthy that also transgenicmice lacking 5-HT1A
eceptors appear as extremelyuseful tools to study the involvement
f serotonin-mediated modulations of various types of functions,
hether at a neuropharmacological or a behavioural level [e.g.,
3,134]. These tools, however,will not be considered herein, as they
ost often if not systematically lack on neuroanatomical selectiv-
ty.
Many studies using approaches relying upon intraparenchymal
rug infusions were conducted in order to characterize the cog-
itive effects of an action on the 5-HT1A receptors of the dorsal
ippocampus or the raphe nucleus [e.g., 30–32,49,50,53,128–130].
or instance, Egarisha and coworkers [53] showed that the micro-
njection of 8-OH-DPAT into the dorsal hippocampus produced
n impairment of spatial memory. Moreover, this impairment
as completely reversed by systemic administrations of 5-HT1A
eceptor antagonists [53]. Generally, all the data described in the
iterature clearly point to an 8-OH-DPAT-induced impairment of
patial memory when the drug is injected into the hippocampus.
sing the same kind of approaches, two other studies showed that
ral Br
t
r
t
b
O
w
w
W
a
M
r
5
t
C
a
8
t
h
o
i
o
8
a
i
3
u
t
a
o
t
a
t
t
t
O
t
f
t
i
a
e
e
c
r
i
i
p
a
r
b
g
m
o
s
t
e
r
s
a
i
o
s
u
4
u
e
s
s
t
a
a
s
a
c
o
e
c
t
p
m
m
e
t
w
c
i
i
4
r
o
a
t
o
p
s
w
r
o
r
4
e
a
t
b
w
l
o
l
a
s
u
e
p
y
i
a
previous day as compared to chance (within subjects comparison)
or to 8-OH-DPAT-treated rats (between subjects comparison). SuchH. Jeltsch-David et al. / Behaviou
here could be a hippocampal asymmetry as to the behavioural
esponses to the 5-HT1A receptor agonist 8-OH-DPAT [13,14]. In
hat way, the ﬁrst study was conducted in order to examine the
ehavioural responses to unilateral and bilateral injections of 8-
H-DPAT into the hippocampal CA1 area of male Wistar rats. It
as found that 8-OH-DPAT increased locomotor activity, which
as most pronounced with injections into the left hippocampus.
hen injected into the right hippocampus, however, the agonist
lso impaired learning and memory, and produced anxiety [13].
ore recently, themodulation of learning andmemory after left or
ight intrahippocampal microinjections of 8-OH-DPAT and of the
-HT1A receptor antagonist NAN190 were more precisely charac-
erized [14]. Microinjections of 8-OH-DPAT into the right or left
A1 region produced a signiﬁcant decrease in the number of avoid-
nces in a shuttle box, this effect being more pronounced when
-OH-DPAT was injected into the right hippocampus as compared
o the left one. Microinjections of NAN190 into the right or left CA1
ippocampal area produced a signiﬁcant increase in the number
f avoidances in a shuttle box, right microinjections of NAN190
ncreasing the number of avoidances more markedly than the left
nes. These stronger memory-modulating effects after injection of
-OH-DPATorNAN190 into the right CA1hippocampal area suggest
rightward bias in the rat. Concerning intra-raphe nuclei admin-
strations of 8-OH-DPAT, several studies were conducted [e.g.,
0,49,128,129]. Carli and her coworkers [30] showed that the stim-
lation of 5-HT1A receptors in the raphe by 8-OH-DPAT reversed
he deﬁcit caused by intrahippocampal scopolamine. Concerning
nxiety behaviours, a wealth of evidence supports the involvement
f certain serotonergic raphe neurons in these functions. In order
o evaluate the role of these neurons in the regulation of inhibitory
voidance, which had been related to generalized anxiety, Dos San-
os and his coworkers [49] submitted rats to the elevated T-maze
est after intra-raphe administration of different drugs changing
he activity of serotonergic neurons. Intra-raphe injections of 8-
H-DPAT and WAY 100635 affected inhibitory avoidance. While
he former inhibited the acquisition of this behaviour, the latter
acilitated it. These data showed that the serotonergic neurons of
he raphe nuclei may play an important role in anxiety process-
ng, with possible implications in pathologies such as generalized
nxiety disorders.
Several tasks in which 5-HT1A receptor-mediated effects were
videnced depend upon hippocampal functions. Surprisingly
nough, the septal region, which is one of the essential nuclei
onnected with the hippocampus, has received limited attention
egarding the possibility for its 5-HT afferents to modulate its
mplications in hippocampal functions. Actually, this structure is
nvolved in memory [138], contains neurons that provide the hip-
ocampus with the major part of its cholinergic innervation [51],
nd is the target of a serotonergic innervation originating in the
aphe nuclei [1,105]. Furthermore, it shows a high density of 5-HT1A
inding sites [38,115]. Some of these sites are located on choliner-
ic neurons, others on GABAergic ones [81,92]. All these elements
ake this region a potential neuroanatomical substrate for direct
r indirect 5-HT1A-mediated interactions between cholinergic and
erotonergic systems.
Nevertheless, little is known about the implication of these sep-
al receptors in behaviour and cognitive processes. Concerning the
ffects of themixed 5-HT1A/7 agonist, 8-OH-DPAT, itwas principally
eported that its intraseptal injection increases maternal aggres-
ive behaviour [45], inﬂuences anxiety [46,99,103], and induces
ntidepressant-like effects [47,95,127]. On the other hand, when
nfused into the lateral septum, 8-OH-DPAT impairs the retention
f a passive avoidance [87]. However, a possible involvement of
eptal 5-HT1A receptors in spatial memory is as to yet poorly doc-
mented.
b
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.1. Acquisition of a reference-memory task in the water maze
nder activation of septal 5-HT1A receptors
In 2000, Bertrand et al. [17] published the results of a ﬁrst
xperiment that assessed the effects of an 8-OH-DPAT-induced
timulation of these receptors on the acquisition of a standard ver-
ionof theMorriswater-maze task. In this task, Long-Evans rats had
o use spatial information to acquire declarative-like knowledge
bout the location of an escape platform that was always hidden
t the same place, right underneath the water surface. Thus, over
uccessive acquisition trials, experimental animals had to construct
task-speciﬁc representation requiring encoding and progressive
onsolidationof amemory,which theyhad to retrieveupon request
n subsequent trials or during the probe trial. Ten minutes before
ach training session the rats were microinjected with artiﬁcial
erebrospinal ﬂuid, or with 0.5 or 4.0g of 8-OH-DPAT. Intrasep-
al microinjections of 8-OH-DPAT impaired, but did not completely
revent, acquisition of the reference memory task in the water
aze, suggesting that an activation of the 5-HT1A receptors of the
edial septum may alter spatial memory formation.
With the protocol used in this study, it was not possible, how-
ver, to know ifmemory formation (encoding, consolidation) rather
han retrieval was affected by 8-OH-DPAT. Indeed, as 8-OH-DPAT
as infused right before each daily acquisition session, the drug
ould have interfered with encoding as well as with post-trial
nformation consolidation processes, or even with the retrieval of
nformation that might have undergone normal consolidation.
.2. Spatial working-memory in a water-maze and septal 5-HT1A
eceptors
In an attempt to extend these results and to further the role
f septal 5-HT1A receptors on cognitive processes, we conducted
nother series of studies, the ﬁrst of which being using a protocol
hat placed emphasis on spatial working memory. Working mem-
ry supposes information to be held in a memory buffer for a short
eriod of time, in general for as long as it is pertinent in a given
hort-lasting situation. In this study, 8-OH-DPAT (0.5 or 4.0g)
as also directly infused into the medial septum [75]. One set of
ats was testedwith a hidden platform, the other onewith a visible
ne. The location of the platforms was changed every day and all
ats were given two consecutive trials. The intraseptal infusion of
.0g of 8-OH-DPAT signiﬁcantly impaired performance: the rats
xhibited longer distances to reach the hidden platform on trials 1
nd 2, but there was an overall amelioration between both trials. In
he rats infused with 0.5g, there were similar overall alterations,
ut they did not reach signiﬁcance. Such effects were not observed
hen the rats were tested with a visible platform.
A closer examination of the drug-induced impairment raised at
east two questions: did this impairment reﬂect a genuine deﬁcit
f spatial memory? Did it correspond to a more general deﬁcit of
earning abilities? During the ﬁrst of each pair of daily trials, when
rat does not know yet where the platform is located, one optimal
trategy relies on the exploration of all possible places in the pool
ntil the platform is found. Within each of these ﬁrst trials, how-
ver, it is possible that rats can remember former locations of the
latform which they may visit in priority in order to maximise the
ield of their searching displacements. This seemed to be the case
n our control rats. In fact, during their ﬁrst trial, control rats spent
longer time on the place where the platform was located on theehaviour is probably not based on working memory as the delay
eparating two successive sessionswas of 24h. It also strongly sug-
ests that the control rats, not the 8-OH-DPAT-treated ones, were
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ble to remember the platform location from 1 day to the next one.
iven that 8-OH-DPAT rats exhibited a capacity to remember the
ocation of the platform on the second trial, it may be postulated
hat the activation of septal 5-HT1A receptors had in fact compro-
ised some aspects of information consolidation. Alternatively, it
s also possible that 8-OH-DPAT has interfered with a retrieval pro-
ess. In any case, these observations pointed to a possible effect of
he activation of 5-HT1A receptors of the medial septum on forma-
ion of a lasting memory rather than on working memory.
.3. Are 5-HT1A receptors of the medial septum a target of
erotonin-mediated mechanisms underlying encoding and
onsolidation processes?
Data in the literature suggest that systematically administered
-OH-DPAT impairs acquisition and retention in a passive avoid-
nce test, as well as in other tests [35,101,120]. Interestingly, when
njected into the septal region, it was shown that 8-OH-DPAT
mpaired passive avoidance consolidation [87], suggesting that, in
ur last mentioned study [75], the forgetting of the place where
he platform was located on the previous day may be the result of
n interference with a consolidation process rather than with the
apability of retrieving learned information.
As previously stated, some of the cholinergic neurons of the
edial septum projecting to the hippocampus receive seroton-
rgic inputs from the raphe [105] and express 5-HT1A receptors
81]. Therefore, regarding the critical role of the septohippocam-
al cholinergic system in memory processes [11,90,144] as well as
he aforementioned importance of serotonergic–cholinergic inter-
ctions in memory function, it could be hypothesized that the
mpairments observed were related to a reduced cholinergic tone
n the hippocampus. However, it is noteworthy that even large
holinergic lesions in the medial septum and the diagonal band
f Broca do not induce dramatic effects on memory in the water
aze [88]. Thus, alternative hypotheses may be proposed. For
nstance, it was suggested that serotonergic ﬁbres originating in
he raphe nuclei and innervating the medial septum may exert
n inhibitory inﬂuence on the rhythmical ﬁring of septal neurons
2], which, over the past, has not only been considered as one of
he “pacemakers” for the hippocampal theta rhythm [136], but
as also linked to mnesic processes, especially to encoding and
onsolidation [110,137]. Therefore, although the type of seroton-
rgic receptors involved in the serotonin-mediated inhibition of
edial septal neuronsﬁring is unknown, it is possible that intrasep-
al injections of 8-OH-DPAT interacted with the rhythmical ﬁring
f these neurons, leading to desynchronization of hippocampal
ctivity, and thus to memory disturbance or to a more general dis-
rganization of behaviour in the water maze. Electrophysiological
pproaches should contribute to further investigate the latter pos-
ibility. In conclusion, we noticed that the stimulation of 5-HT1A
eceptors in the septal region of rats by local injections of 8-OH-
PAT induced a complex pattern of deﬁcits in a water-maze task.
ased on the characteristics of the observed deﬁcits, we raised the
ossibility that the 8-OH-DPAT-induced impairment, rather than
eing only the result of a true alteration of workingmemory, in fact
eﬂected a more global cognitive deﬁciency in which alteration of
emory capacities were mixed with attention dysfunctions and
lterations of search strategies.
.4. 5-HT1A receptors in the medial septum and
ncoding/consolidation of reference memory in the water-mazeMore recently, we continued the characterization of the role of
-HT1A receptorsof themedial septum,particularlyby trying toﬁnd
ut if the drug was altering encoding, consolidation or retrieval of
patial information. Based on a series of experiments conducted in
4
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ur laboratory, for which we went back to a testing protocol taxing
eference memory, we could show that the activation of septal 5-
T1A receptors altered spatial memory encoding, interfered with
onsolidation in a particular way (see below), but did not affect
etrieval of the platform location in a water-maze task [84]. As for
he other studies depicted previously, this experiment was con-
ucted in Long-Evansmale rats. The testing protocol (3 consecutive
ays of acquisition, 4 consecutive trials per day, and a 24-h delayed
robe trial)was ﬁrst validated by showing that (i) ratswere actually
ble to acquire the location of the hidden platform and to retrieve it
n thedelayedprobe trial and (ii) reversible lidocaine-induced inac-
ivation of the septal region disrupted acquisition and retrieval of
he task. Different series of rats were then infusedwith 8-OH-DPAT
t the dose of 4.0g, which was the most efﬁcient one among the
wo doses used in our previous experiments [17,75]. To test for pos-
ible interactions with encoding and/or consolidation, some rats
ere infused right before each acquisition session. To test for pos-
ible interactions with consolidation, other rats were infused with
-OH-DPAT immediately or at variable intervals (1–6h) after each
cquisition session. Finally, to test for possible interactions with
etrieval, the performance of a last set of rats was evaluated once
he task was acquired over drug-free sessions, but the infusion was
ade rightbefore thedelayedprobe trial.Wealsoassessedwhether
he 8-OH-DPAT-induced effects were resistant to the blockade of 5-
T1A (usingWAY 100635) or 5-HT7 receptors (using SB 269970). SB
69970wasusedbecause8-OH-DPATalsobinds to5-HT7 receptors,
hich are present in the septal region of rodents [22,63]. Comple-
entary experiments were conducted to exclude the possibility
hat the effects of 8-OH-DPAT on water-maze performance were
iased bymotivational, sensorimotor, locomotor or anxiety-related
ide effects [84].
It was found that 8-OH-DPAT infusions disabled learning of the
ocation of a hidden platform, and this effect was counterbalanced
y systemic or intraseptal pre-treatment with the selective 5-HT1A
eceptor antagonist WAY 100635. It is noteworthy that the effects
f the 5-HT7 antagonist did not prevent the 8-OH-DPAT-induced
eﬁcits in a signiﬁcant way. When the platform was visible, 8-
H-DPAT did not disrupt performance, suggesting no interference
f motivation, sensorial or motor coordination biases with cogni-
ive capabilities. When 8-OH-DPAT was infused immediately, or 1,
or 6h after each series of acquisition trials, performance in the
elayed probe trial was comparable to that of controls, indicat-
ng unaltered consolidation. It is noteworthy, however, that when
he infusions occurred 2h after each acquisition session, the rats
ailed to search for the platform at the appropriate place during
he subsequent probe trial. Finally, when 8-OH-DPAT was infused
ight before a probe trial after drug-free acquisition, performance
as comparable to that of controls, suggesting no interference of
-OH-DPAT with retrieval processes. Given that, in addition to the
isible platform data (rats swam to the platform, regardless of
reatment), 8-OH-DPAT infusions altered neither activity levels in
he home cage, nor anxiety-related behaviour in an elevated plus-
aze, these ﬁndings can be interpreted in relation with dynamics
f learning and memory processes, rather than with non-cognitive
iases. Therefore, the aforementioned results indicate that 5-HT1A
eceptors-driven mechanisms in the septal region play an impor-
ant role in the regulation of hippocampus-dependent information
ncoding and, within a given post-acquisition time window, par-
icipate in consolidation..5. What kind of septal neurons participate in the
-OH-DPAT-induced effects on encoding/consolidation?
As stated above, in the septal region, 5-HT1A receptors are
ocated on both cholinergic [e.g., 81,92] and GABAergic neurons
H. Jeltsch-David et al. / Behavioural Brain Research 195 (2008) 86–97 93
Fig. 1. Schematic illustrationofourhypothesis on the roleof septal 5-HT1A receptors (white squares) in theencodingandconsolidationofhippocampal-dependent information
during acquisition. When the serotonergic tonus in the septum is high (top), 5-HT1A undergo strong activation, whereby the activation of cholinergic and GABAergic neurons
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cs reduced and both encoding and consolidationmay bemore difﬁcult.When the ser
hereby the activation of cholinergic and GABAergic neurons is facilitated and both
nvestigations, but it is compatiblewithﬁndings showing that lesions of bothGABAer
r consolidation-related activity in the hippocampus, namely theta activity, but also
92]. As each of these neurons may contribute to, and even to some
xtent cooperate in, hippocampal-dependent learning and mem-
ry processes [e.g., 52,89,102,112], the next step of our approach
onsisted in testing whether our 8-OH-DPAT-induced effects could
e attributed to an action of the drug on septal cholinergic neu-
ons. Here, our reasoning was by elimination. In fact, we had two
uestions: can extensive cholinergic lesions in the septal region
imic the effects of 8-OH-DPAT? If not – which was expectable
iven the literature on the effects of cholinergic lesions conﬁned
o this region; see above – do such lesions alter the effects of
-OH-DPAT? The cholinergic lesions were produced by intrasep-
al infusions of 192 IgG-saporin using the infusion devices to be
sed for the subsequent 8-OH-DPAT infusions. Thus, the lesions tar-
eted the medial septum. As such lesions generally require about
0 days to reach their maximal extent [141], we started to train
ur rats after an 11-day post-surgical recovery time. Part of them,
hich served as controls, were infused with a PBS solution before
ach acquisition trial, the other ones being subjected to 8-OH-
PAT infusions instead (4g). This yet unpublished studybyKoenig
t al. yielded several interesting results. First, we conﬁrmed that
re-acquisition infusions of 8-OH-DPAT prevented learning and
ubsequent recall of the task. Second, selective cholinergic lesions
n the medial septum did not mimic the effects induced by 8-OH-
PAT in sham-operated rats; despite the lesions, the rats given
BS infusions acquired the task, and their retrieval performance
as comparable to that of unlesioned controls. Third, the effects
f pre-acquisition 8-OH-DPAT infusions on learning capabilities
ere comparable in control and lesioned rats, whether they had
eenpreviously familiarized or notwith the learning test. Although
art of the cholinergic neurons located in the medial septum bear
-HT1A receptors, the present results demonstrate that these are
robably not the most important ones to be involved in the 8-OH-
PAT-induced impairments of water-maze learning. Because most
f not almost all GABAergic neurons in the medial septum possess
-HT1A receptors, it is possible that a concomitant 8-OH-DPAT-
nduced hyperpolarization of cholinergic and GABAergic neurons,
r hyperpolarization of only GABAergic ones under the condition
f cholinergic damage is necessary to obliterate the acquisition of a
t
e
t
t
egic tonus in the septum is low (bottom), 5-HT1A receptors undergoweak activation,
ding and consolidation may more easy. This hypothesis is clearly requiring further
d cholinergic neurons in themedial septumdoonlyweaken an important encoding-
memory functions [e.g., 10,15,40,48,82,108,109,142].
latform location in this task. For instance, when both populations
f neurons are damaged, there are memory deﬁcits which lesions
f each population alone are unable to induce [113,147]. These
ata could indicate that processes conjointly mediated by cholin-
rgic and GABAergic neurons of the septum, and which undergo
erotonergic modulation involving 5-HT1A receptors, could be nec-
ssary for normal encoding and perhaps consolidation of spatial
ippocampus-dependent memories. Further studies should now
ocus on the role of GABAergic neurons of the septal region in the
onstitution of a spatial memory. Given the available experimen-
al evidence [e.g., 10,15,40,48,82,112,113,147], one may predict that
ombined cholinergic and GABAergic lesions in the medial sep-
um could result in a disruption of encoding and consolidation of
patial memories, which should be comparable to the disruption
nduced by infusions of 8-OH-DPAT in intact rats. This hypothesis
s illustrated in Fig. 1. Another possibility to further this issuemight
onsist in investigating the effects onmemory of intrahippocampal
nfusions of a cholinergic agonist and/or a GABAergic ligand in rats
ubjected to an intraseptal infusion of 8-OH-DPAT right before the
cquisition sessions of a water-maze task.
. Conclusions
The literature contains a series of experimental arguments
nding their roots in histological, electrophysiological, pharma-
ological and behavioural research ﬁelds, and demonstrating or
uggesting that, in the mammalian brain, cholinergic function may
e under serotonergic modulatory inﬂuence. Furthermore, as doc-
mented anddiscussedherein, thismodulationmayhave cognitive
mplications. These remarks, however, call several observations.
irst, 5-HT1A receptors are not the only ones to be involved in
uch modulation. Second, if there is evidence that cognitive pro-
esses involve cholinergic functions, but cannot be reduced to
hem in an exclusive way, these processes also cannot be fully
xplained by an additional consideration of serotonergic modula-
ory mechanisms. Third, a given function that would be sensitive
o conjoint cholinergic and serotonergic manipulations is not nec-
ssarily under the direct control of a cholinergic mechanismwhich
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ould be more or less active depending on the level reached
y the serotonergic tonus. It is well possible, indeed, that this
unction requires both neurotransmitter systems to cooperate in
parallel, complementary and perhaps even synergistic way to
perate normally (which is our hypothesis as regards the choliner-
ic and GABAergic septohippocampal projections). Fourth, it must
e emphasized that interactions involving neurotransmitter sys-
ems other than the serotonergic one have also been dealt with in
ognitive neuroscience and psychopharmacology, and that there
s clear evidence that the activity of cholinergic neurons is also
nder themodulatory inﬂuence of other neurotransmitter systems
36,72,78].
Moreover, it must be kept inmind that the cholinergic hypothe-
is ofmemory dysfunctions has been challenged recently [102,114],
ainly because highly selective cholinergic lesions in the basal
orebrain produce onlyweak effects on learning andmemory capa-
ilities. An important tool in this line of investigations has been
92 IgG-saporin [143,144]. Therefore, if cholinergicmechanismsare
ot central to cognitive functions (which obviously requires fur-
her investigations), the idea that the contribution of serotonin to
ognition is mediated by a serotonin-operated modulation of the
unctional state of cholinergic neurons of the basal forebrain must
lso be reconsidered.
Nevertheless, to question the role of these serotoner-
ic/cholinergic interactionsmay be important for different reasons.
irst, there are neurological disorders such as dementia of the
lzheimer type or Parkinson’s disease,with alterations in both (and
lso other) neurotransmitter systems, and therapeutic approaches
iming at reducing the severity of the cognitive symptomatology
ay have to consider dysfunctions in a multiplicity of neurotrans-
itter systems for the development of treatment strategies that
ight reveal more effective in tackling the disease-related symp-
oms [59]. This would mean that if highly speciﬁc ligands are well
dapted to study the functional contributions of particular recep-
ors, less speciﬁcones couldbemore appropriate to treat symptoms
ssociated with neurodegenerative diseases. Along this line and
s regards Alzheimer’s disease, for instance, the “monotransmit-
er” therapies used or proposed so far may reveal too limited,
nd 5-HT1A receptors appear to be a particularly relevant comple-
entary target [124–126]. These receptors are also interesting for
ther reasons. There are drugs frequently used for the treatment of
sychiatric disorders which affect not only one neurotransmitter
ystem, but both serotonergic and cholinergic neurotransmissions.
or example, many tricyclic antidepressants are known to impair
ognitive performance, an effect which has been attributed to their
nticholinergic properties regardless of their serotonergic effects.
herefore, it seems possible that the combination of decreased
holinergic and increased serotonergic activity does in fact con-
ribute to amplify the cognition impairing effects of these drugs.
his possibility clearly requires further exploration. Our recent
ndings on the role of septal 5-HT1A receptors suggest that these
eceptors contribute to a mechanism involved in the encoding
nd consolidation of hippocampal-dependent knowledge, which
hey may contribute to impair when activated in the septal region.
hese ﬁndings might have some relevance to approaches rely-
ng upon the modiﬁcation of serotonergic functions in the brain
or treating psychiatric disorders such as e.g., depression, anxi-
ty or post-traumatic stress. Concerning depression, for instance,
elective serotonin reuptake inhibitors (SSRI) have the best safety
ecord among the different therapeutic options [135], but there is
literature reporting on possible SSRI-related memory problems
62,80,139]. Although these memory problems could be related to
arious confounding factors (subject’s history, age, existenceof age-
elated cognitive dysfunctions, etc.), in addition to depression itself,
he fact that the activation of 5-HT1A receptors in the septal regionain Research 195 (2008) 86–97
roduces adverse effects onmemory functions allowsus to propose
part of) a possible neuropharmacological substrate that could be
nvolved in the cognitive dysfunctions associated with drug thera-
ies increasing the serotonergic tonus, namely the5-HT1A receptors
ocated in the septal region.
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